A Somerset woman says she suffered a severe asthma attack after having her prescription changed without consultation. Sue* ...

Asthma is a prevalent, chronic respiratory disease affecting as many as 262 million people worldwide, 2 including over 25 million in the US. 3 When uncontrolled, inflammation and muscle tightening in ...

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Shares in the Cambridge, England-based pharmaceutical company rose ...

(Reuters) -AstraZeneca breached the UK pharmaceutical industry’s code of practice by using a claim that misleadingly implied its Symbicort asthma drug was suitable for all newly diagnosed patients ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

Stephen Hughes receives research grant funding from the Australian Government Department of Health and Aged Care Medical Research Future Fund, The Australian Research Council and Asthma Australia. He ...

On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials ...

MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...